公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study | CHIH-HUNG HSU ; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN ; YU-YUN SHAO ; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU ; ANN-LII CHENG | Oncology (Switzerland) | 40 | 41 | |
2015 | CAPER Is Vital for Energy and Redox Homeostasis by Integrating Glucose-Induced Mitochondrial Functions via ERR-�\-Gabpa and Stress-Induced Adaptive Responses via NF-�eB-cMYC | Kang Y.K.; Putluri N.; Maity S.; Tsimelzon A.; Ilkayeva O.; Mo Q.; Lonard D.; Michailidis G.; Sreekumar A.; Newgard C.B.; Wang M.; Tsai S.Y.; Tsai M.-J.; O'Malley B.W.; MING-JER TSAI | PLoS Genetics | 19 | 18 | |
2014 | E2/estrogen receptor/Sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity | Kang Y.K.; Jung S.Y.; Qin J.; Li C.; Tsai S.Y.; Tsai M.-J.; O'Malley B.W.; MING-JER TSAI | Molecular and Cellular Biology | 2 | 2 |